Glavine Paul
Reporting owner on Forms 3, 4 and 5, CIK 2118509.
Glavine Paul reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-01.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Helus Pharma Inc. CIK 1833141 | director, officer (Chief Growth Officer) | 1 | 2026-10-01 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Helus Pharma Inc. Common Shares | 2026-09-30 | A granted | +248,000 | 4,750,191 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000912282-26-001332 | Helus Pharma Inc. | 2026-10-01 |